Search for: "Merck and Co,"
Results 441 - 460
of 1,277
Sort by Relevance
|
Sort by Date
5 Mar 2012, 12:24 pm
Merck & Co., No. 111438, slip op. [read post]
5 Mar 2012, 6:18 am
Merck & Co., No. 111438, Slip op. [read post]
2 Mar 2012, 6:52 am
Merck (Vioxx) Trial2006-05-08 Doherty v. [read post]
28 Feb 2012, 6:06 pm
The Food and Drug Administration announced on Tuesday the changes to the safety information on the labels of statins such as Pfizer Inc's Lipitor, AstraZeneca's Crestor and Merck & Co's Zocor that are taken by tens of millions of people.Statins have been shown to significantly reduce the risk of heart attack and heart disease, and the FDA said the new information should not scare people into stopping taking the drugs. [read post]
27 Feb 2012, 7:07 am
and Merck & Co Inc.). [read post]
25 Feb 2012, 10:04 am
App. 2009) Merck & Co., Inc. v. [read post]
24 Feb 2012, 2:08 pm
Merck & Co., Inc., 09 Civ. 6948 (JFK), is scheduled for trial on September 10, 2012. [read post]
23 Feb 2012, 11:45 am
Merck & Co., No. 11-cv-02680-RBJ-KLM (D. [read post]
21 Feb 2012, 2:58 am
See Merck & Co. v. [read post]
18 Feb 2012, 9:11 am
The lawsuit names Merck & Co., Organon Pharmaceuticals, Akzo Nobel NV and Schering-Plough Corporation as defendants. [read post]
17 Feb 2012, 12:28 pm
NuvaRing is marketed by Merck & Co. [read post]
17 Feb 2012, 11:29 am
In our rather terse (due to firm involvement) post on Monday concerning Merck & Co. v. [read post]
16 Feb 2012, 5:00 am
Frazier Chairman of the Board, President and Chief Executive Officer Merck & Co., Inc. [read post]
13 Feb 2012, 9:08 am
We can’t say all that much about Merck & Co. v. [read post]
11 Feb 2012, 7:08 pm
Merck & Co. currently faces hundreds of Fosamax fracture lawsuits that have been filed by individuals who claim the drug maker failed to adequately warn about the potential risk of problems. [read post]
10 Feb 2012, 10:32 am
Venable last October successfully defended the pharmaceutical giant Merck & Co. [read post]
10 Feb 2012, 8:42 am
See Merck & Co. v. [read post]
8 Feb 2012, 7:23 am
An experimental anti-clotting drug that Merck & Co. is developing was found to increase risk of dangerous internal bleeding in a second study, meaning it's unlikely to achieve the blockbuster status once expected — if it's even approved.Vorapaxar is part of a new generation of anti-clotting drugs meant to prevent the death and disability strokes and heart attacks cause in the millions of people at risk for them. [read post]
27 Jan 2012, 4:00 pm
Respondents Merck & Co., Inc., Schering Plough Corporation, Organon Inc., and N.V. [read post]
27 Jan 2012, 11:20 am
Kanas 1977-2006 $214,300,000 Merck & Co., Inc. [read post]
